NEW YORK, Nov. 25, 2025 /PRNewswire/ — Nucs AI, the leader in AI-based radiology solutions, today announced the launch of TrackPSMA, a breakthrough tool that gives physicians a faster, quantitative way to evaluate treatment response in prostate cancer.
PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has expanded the indication for the Bracco-branded Max 3™, a Rapid Exchange and Syringeless Injector for use in magnetic resonance imaging (MRI) procedures. In addition to single-dose and multi-dose vials, the Max 3™ system is now indicated for use with the newly approved VUEWAY® (gadopiclenol) injection Imaging Bulk Package (IBP) in 30 mL and 50 mL formats.
RESTON, Va., Nov. 25, 2025 /PRNewswire/ — VSI® Spine Surgeon Dr. Christopher Good has achieved a historic milestone in robotic spine surgery, performing the world’s first minimally invasive robotic Bertolotti’s resection surgery at Reston Hospital Center (HCA Virginia Health System). This first-ever procedure introduces a transformative surgical option for patients suffering from chronic low back pain caused by Bertolotti syndrome, an underdiagnosed spinal condition affecting an estimated 4-8% of the population.
Researchers at the Icahn School of Medicine at Mount Sinai have discovered how to reverse aging in blood-forming stem cells in mice by correcting defects in the stem cell’s lysosomes. The breakthrough, published in Cell Stem Cell, identifies lysosomal hyperactivation and dysfunction as key drivers of stem cell aging and shows that restoring lysosomal slow degradation can revitalize aged stem cells and enhance their regenerative capacity.
Researchers at Johns Hopkins Medicine say they have used a “zap-and-freeze” technology to watch hard-to-see brain cell communications in living brain tissue from mice and humans.
The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive surgical margins occur in 15–40% of prostate cancer cases, the risk of postoperative recurrence and functional impairment is significantly increased.
Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant boost in the form of a new technique from St. Jude Children’s Research Hospital
Scientists believe the proteins (PLAUR, SERPINA3, CRIM1, DDR1 and LTBP2), that play key roles in the development of diseases such as cancer and inflammation, may also contribute to the risk of dying.
Researchers have created an artificial intelligence model that can identify which mutations in human proteins are most likely to cause disease, even when those mutations have never been seen before in any person.
Patients with the deadliest form of brain cancer, glioblastoma, who received MRI-guided focused ultrasound with standard-of-care chemotherapy had a nearly 40% increase in overall survival in a landmark trial of 34 patients led by University of Maryland School of Medicine (UMSOM) researchers.